Evidence map›Paper›PMID 23283923›Full record

Trial reportJournal of the American Dental Association (1939)2013

Results from the Xylitol for Adult Caries Trial (X-ACT).

James D Bader, William M Vollmer, Daniel A Shugars, Gregg H Gilbert, Bennett T Amaechi, John P Brown, Reesa L Laws, Kimberly A Funkhouser, Sonia K Makhija, André V Ritter and 1 more

Abstract readClinical Trial, Phase IIIComparative StudyMulticenter Study
In one paragraph

Trial report in Journal of the American Dental Association (1939), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. The effect of allulose, sucralose, and xylitol onJADA foundational science · 2025
    Article
  6. Is xylitol effective in the prevention of dental caries? A systematic review.Journal of clinical and experimental dentistry · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

James D BaderSchool of Dentistry, University of North Carolina at Chapel Hill, CB#7450, Chapel Hill, N.C. 27599-7450, USA. jim_bader@unc.edu
William M Vollmer
Daniel A Shugars
Gregg H Gilbert
Bennett T Amaechi
John P Brown
Reesa L Laws
Kimberly A Funkhouser
Sonia K Makhija
André V Ritter
Michael C Leo
Kaiser Permanente · USThe University of Texas Health Science Center at San Antonio · USUniversity of Alabama · USUniversity of North Carolina at Chapel Hill · US

Funding

Xylitol Adult Caries Trial (X-ACT) Data Coordinating CenterU01DE018047 · NIDCR · KAISER FOUNDATION RESEARCH INSTITUTE · PI VOLLMER, WILLIAM MARION · 2006 to 2011
$3.3M
Xylitol Adult Caries Trial (X-ACT): UAB Clinical CenterU01DE018049 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILBERT, GREGG H · 2006 to 2010
$1.2M
Xylitol Adult Caries Trial (X-ACT) UTHSC San Antonio Clinical CenterU01DE018050 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI AMAECHI, BENNETT TOCHUKWU · 2006 to 2010
$1.1M
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical CenterU01DE018048 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHUGARS, DANIEL A · 2006 to 2010
$954k
Xylitol Adult Caries Trial (X-ACT)--Study Chair applicationU01DE018038 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BADER, JAMES D · 2006 to 2010
$461k
NIDCR NIH HHS U01 DE018038NIDCR NIH HHS U01DE018038NIDCR NIH HHS U01 DE018047NIDCR NIH HHS U01DE018047NIDCR NIH HHS U01 DE018048NIDCR NIH HHS U01DE018048NIDCR NIH HHS U01 DE018049NIDCR NIH HHS U01DE018049NIDCR NIH HHS U01 DE018050NIDCR NIH HHS U01DE018050
6 · The paper itself

Abstract

backgroundAlthough caries is prevalent in adults, investigators have tested few preventive therapies in adult populations. In a randomized controlled trial, the authors evaluated the effectiveness of xylitol lozenges in preventing caries in adults at elevated risk of developing caries.

methodsThe Xylitol for Adult Caries Trial (X-ACT) was a three-site placebo-controlled randomized trial. Participants (n = 691) aged 21 through 80 years consumed five 1.0-gram xylitol or placebo lozenges daily for 33 months. They underwent clinical examinations at baseline and at 12, 24 and 33 months.

resultsXylitol lozenges reduced the caries increment 10 percent. This reduction, which represented less than one-third of a surface per year, was not statistically significant. There was no indication of a dose-response effect.

conclusionsDaily use of xylitol lozenges did not result in a statistically or clinically significant reduction in 33-month caries increment among adults at an elevated risk of developing caries. CLINICAL IMPLICATIONS: These results suggest that xylitol used as a supplement in adults does not reduce their caries experience significantly.

Indexed as

Administration, OralAdultAgedAged, 80 and overCariostatic AgentsCrownsDental CariesDental Caries SusceptibilityDental EnamelDental Restoration, PermanentDentinDMF IndexDouble-Blind MethodFemaleFluoridesFollow-Up StudiesCariostatic AgentsFluoridesPit and Fissure SealantsPlacebosSweetening AgentsXylitol

Identifiers

PMID23283923
PMCPMC3926805
OpenAlexW1990261288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.